Chiome Bioscience Inc. announced non-consolidated earnings results for the six months ended June 30, 2016. For the period, the company reported net sales of JPY 130 million, operating loss was JPY 582 million, ordinary loss was JPY 580 million and net loss was JPY 711 million or net loss per share of JPY 31.99. Net cash used in operating activities was JPY 569,648,000. Purchase of property and equipment was JPY 5,916,000.